InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: antihama post# 2431

Friday, 01/11/2019 10:27:03 AM

Friday, January 11, 2019 10:27:03 AM

Post# of 3283
Do you have any opinion on potential Rolontis sales? My only point of reference for this is the enthusiasm shown by JT and the fact that he has added Rolontis veterans to the BOD.

I don't think JT would/should be excited about Rolontis unless he expects to make a significant dent in the market. To me that a minimum of $300M and more likely $500M+. For me this is a first major test of JTs credibility.

I think Qapzola is $200M+ per year even if it eventually faces generics. JT is very low key about Qapzola. That angers me.